Advertisement
U.S. Markets closed

Sea Mild Biotechnology Co., Ltd. (7516.TWO)

Taipei Exchange - Taipei Exchange Delayed Price. Currency in TWD
9.20-0.34 (-3.56%)
At close: 02:59PM CST
Currency in TWD

Valuation Measures4

Market Cap (intraday) 177.64M
Enterprise Value 188.73M
Trailing P/E 9.11
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)0.66
Price/Book (mrq)2.06
Enterprise Value/Revenue 0.70
Enterprise Value/EBITDA 5.19

Trading Information

Stock Price History

Beta (5Y Monthly) -0.83
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 312.70
52 Week Low 38.20
50-Day Moving Average 39.51
200-Day Moving Average 39.75

Share Statistics

Avg Vol (3 month) 349.9k
Avg Vol (10 day) 333.38k
Shares Outstanding 519.31M
Implied Shares Outstanding 6N/A
Float 817.59M
% Held by Insiders 1N/A
% Held by Institutions 1N/A
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2769:1000
Last Split Date 3Jan 21, 2021

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Jun 30, 2024

Profitability

Profit Margin 7.23%
Operating Margin (ttm)6.12%

Management Effectiveness

Return on Assets (ttm)3.42%
Return on Equity (ttm)25.45%

Income Statement

Revenue (ttm)269.5M
Revenue Per Share (ttm)13.96
Quarterly Revenue Growth (yoy)10.10%
Gross Profit (ttm)N/A
EBITDA 13.97M
Net Income Avi to Common (ttm)19.48M
Diluted EPS (ttm)1.01
Quarterly Earnings Growth (yoy)531.30%

Balance Sheet

Total Cash (mrq)63.42M
Total Cash Per Share (mrq)3.28
Total Debt (mrq)67.48M
Total Debt/Equity (mrq)78.28
Current Ratio (mrq)1.26
Book Value Per Share (mrq)4.47

Cash Flow Statement

Operating Cash Flow (ttm)-810k
Levered Free Cash Flow (ttm)2.51M